In Brief: Novartis Actigall
Executive Summary
Novartis Actigall: Company launches ursodiol capsules for the prevention of gallstones in obese patients experiencing rapid weight loss. The supplemental indication was cleared by FDA in March 1996. The cost of the recommended course of therapy (300 mg taken twice daily for 4-6 months) is between $545 and $815 AWP. Novartis will support the launch with direct mail to physicians, but is not using its detail force...